AIG
RCUS icon

American International Group’s Arcus Biosciences RCUS Stock Holding History

American International Group’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-29,014
Closed -$548K – 2110
2024
Q1 		$548K Sell
29,014
-252
-0.9% -$4.36K ﹤0.01% 1601
2023
Q4 		$559K Buy
29,266
+281
+1% +$4.49K ﹤0.01% 1602
2023
Q3 		$520K Buy
28,985
+667
+2% +$13.4K ﹤0.01% 1583
2023
Q2 		$575K Buy
28,318
+231
+0.8% +$4.4K ﹤0.01% 1557
2023
Q1 		$512K Buy
28,087
+120
+0.4% +$2.29K ﹤0.01% 1590
2022
Q4 		$578K Sell
27,967
-209
-0.7% -$5.75K ﹤0.01% 1512
2022
Q3 		$737K Buy
28,176
+699
+3% +$18.5K 0.01% 1355
2022
Q2 		$696K Buy
27,477
+5,219
+23% +$128K ﹤0.01% 1405
2022
Q1 		$702K Sell
22,258
-1,565
-7% -$52.4K ﹤0.01% 1533
2021
Q4 		$964K Sell
23,823
-974
-4% -$37.8K ﹤0.01% 1455
2021
Q3 		$865K Sell
24,797
-589
-2% -$18.3K ﹤0.01% 1516
2021
Q2 		$697 Buy
25,386
+819
+3% +$23.4K ﹤0.01% 1729
2021
Q1 		$690 Buy
24,567
+65
+0.3% +$2.26K ﹤0.01% 1663
2020
Q4 		$636 Sell
24,502
-703
-3% -$17K ﹤0.01% 1625
2020
Q3 		$432K Buy
25,205
+5,067
+25% +$113K ﹤0.01% 1666
2020
Q2 		$498K Buy
20,138
+919
+5% +$24.8K ﹤0.01% 1593
2020
Q1 		$267K Sell
19,219
-1,109
-5% -$13.8K ﹤0.01% 1747
2019
Q4 		$205K Sell
20,328
-172
-0.8% -$1.45K ﹤0.01% 2208
2019
Q3 		$187K Buy
20,500
+450
+2% +$3.62K ﹤0.01% 2207
2019
Q2 		$159K Buy
20,050
+37
+0.2% +$370 ﹤0.01% 2381
2019
Q1 		$250K Sell
20,013
-650
-3% -$7.05K ﹤0.01% 2095
2018
Q4 		$223K Buy
20,663
+14,503
+235% +$169K ﹤0.01% 2122
2018
Q3 		$86K Buy
6,160
+2,794
+83% +$35.6K ﹤0.01% 2910
2018
Q2 		$41K Buy
+3,366
New +$52.8K ﹤0.01% 3014

Other funds holding RCUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

American International Group's RCUS Position: Q2 2024 in Review

American International Group sold out of Arcus Biosciences (RCUS) in Q2 2024, closing a stake of 29,014 shares — an estimated $548K sold.

American International Group first reported a position in RCUS in Q2 2018 and held it in 24 quarters. The position peaked at $964K in Q4 2021. 193 funds tracked by Wall St. Rank hold RCUS as of Q2 2024.

  • American International Group reported no remaining Arcus Biosciences position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 29,014 Arcus Biosciences shares in Q2 2024, an estimated $548K.
  • American International Group first reported a position in Arcus Biosciences in Q2 2018 and held it in 24 quarters.
  • American International Group's Arcus Biosciences position peaked at $964K in Q4 2021.
  • 193 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.